mei6570
mAbexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 15, 2023 (NCT05912218)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Oxidized LDLINHIBITOR
Oxidized LDL inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05912218 | Phase 2 | Jun 15, 2023 | Government of Singapore, Khoo Teck Puat Hospital, National University of Singapore, Singapore General Hospital |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Singapore | Government | 1 | 1 | 1 | 2023 |
| Khoo Teck Puat Hospital | Academic/Hospital | 1 | 0 | 1 | 2023 |
| National University of Singapore | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Singapore General Hospital | Academic/Hospital | 1 | 0 | 1 | 2023 |
4 organizations
Page 1 / 1